US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 1.359
  • +0.039+2.92%
Trading Apr 29 15:12 ET
35.75MMarket Cap-3257P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunoPrecise Antibodies Earnings Date

Currency: CAD

Period

Q3 FY2024 Earnings

Mar 14, 2024

Revenue(YoY)

6.22M

+20.31%
EPS(YoY)

-0.11

+42.11%
Analyst Rating

Buy

Mar 15, 2024

ImmunoPrecise Antibodies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.800M--
--2024/Q4-- / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--
Dec 14, 20232024/Q26.150M / 5.853M--
Sep 14, 20232024/Q15.688M / 5.350M--
Jul 7, 20232023/Q45.621M / 5.706M--
Mar 16, 20232023/Q35.171M / 5.434M--
Dec 15, 20222023/Q25.200M / 5.081M--
Sep 14, 20222023/Q14.700M / 5.300M--
Jul 29, 20222022/Q45.200M / 5.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.800M--
--2024/Q4-- / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--
Dec 14, 20232024/Q26.150M / 5.853M--
Sep 14, 20232024/Q15.688M / 5.350M--
Jul 7, 20232023/Q45.621M / 5.706M--
Mar 16, 20232023/Q35.171M / 5.434M--
Dec 15, 20222023/Q25.200M / 5.081M--
Sep 14, 20222023/Q14.700M / 5.300M--
Jul 29, 20222022/Q45.200M / 5.000M--

Unlock Free Earnings Estimates

ImmunoPrecise Antibodies Earnings Reports

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 08:24 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 08:03 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 23 17:36 ET

  • ImmunoPrecise Antibodies | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Feb 15 15:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 15, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-3.61%